Teva Pharmaceutical Industries (TEVA) Stock Chart & Stock Price History $21.97 +0.29 (+1.32%) As of 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Teva Pharmaceutical Industries Stock Price Performance 5 Day Performance+4.75%1 Month Performance+5.20%3 Month Performance+22.31%6 Month Performance+34.10%Year-To-Date Performance-0.34%1 Year Performance+99.15% Receive TEVA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. Email Address TEVA Stock Chart for Friday, January, 17, 2025 TEVA Chart by TradingView Teva Pharmaceutical Industries Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/17/2025$21.68$21.97+1.34%$21.99$21.218.96 million shs$24.89 billion01/16/2025$21.90$21.68-1.03%$21.86$21.487.20 million shs$24.56 billion01/15/2025$21.01$21.90+4.24%$22.10$21.2311.93 million shs$24.81 billion01/14/2025$20.42$21.01+2.89%$21.02$20.417.96 million shs$23.80 billion01/13/2025$20.97$20.42-2.62%$20.97$20.1515.17 million shs$23.13 billion01/10/2025$21.50$20.97-2.47%$21.40$20.8113.01 million shs$23.76 billion Get the Latest News and Ratings for TEVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. 01/09/2025$21.50$21.50$21.80$21.375.11 million shs$24.36 billion01/08/2025$21.64$21.50-0.65%$21.80$21.375.11 million shs$24.36 billion01/07/2025$21.03$21.64+2.90%$21.79$21.2812.55 million shs$24.52 billion01/06/2025$21.24$21.03-0.99%$21.43$20.929.73 million shs$23.83 billion01/03/2025$21.30$21.24-0.28%$21.58$21.095.19 million shs$24.06 billion01/02/2025$22.04$21.30-3.36%$22.30$21.258.12 million shs$24.13 billion01/01/2025$22.04$22.04$22.57$21.866.32 million shs$24.97 billion12/31/2024$22.32$22.04-1.25%$22.57$21.866.32 million shs$24.97 billion12/30/2024$22.77$22.32-1.98%$22.53$22.009.60 million shs$25.29 billion12/27/2024$22.62$22.77+0.66%$22.80$22.336.93 million shs$25.80 billion12/26/2024$22.42$22.62+0.89%$22.80$22.287.48 million shs$25.63 billion12/25/2024$22.42$22.42$22.50$22.193.03 million shs$25.40 billion12/24/2024$22.21$22.42+0.95%$22.50$22.193.03 million shs$25.40 billion12/23/2024$22.09$22.21+0.54%$22.25$21.5611.77 million shs$25.16 billion12/20/2024$21.31$22.09+3.66%$22.17$21.1112.76 million shs$25.03 billion12/19/2024$21.20$21.31+0.52%$21.64$20.9814.44 million shs$24.14 billion12/18/2024$20.88$21.20+1.53%$21.98$20.4023.68 million shs$24.02 billion12/17/2024$16.50$20.88+26.55%$21.05$19.0357.81 million shs$23.66 billion12/16/2024$16.50$16.50$16.83$16.296.93 million shs$18.69 billion Related Companies GSK Stock Price Chart TAK Stock Price Chart ARGX Stock Price Chart BNTX Stock Price Chart BGNE Stock Price Chart GMAB Stock Price Chart VTRS Stock Price Chart ITCI Stock Price Chart SMMT Stock Price Chart MRNA Stock Price Chart Receive TEVA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Teva Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:TEVA) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
